• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹参酮 IIA 通过抑制 YAP 转录活性抑制宫颈癌干细胞的迁移和侵袭。

Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.

机构信息

Traditional Chinese Medicine Department, Changzhou First People's Hospital, 185th on Juqian street, Changzhou, 213000, China.

Department of Oncology, Changzhou First People's Hospital, 185th on Juqian street, Changzhou, 213000, China.

出版信息

Biomed Pharmacother. 2018 Sep;105:758-765. doi: 10.1016/j.biopha.2018.06.028. Epub 2018 Jun 14.

DOI:10.1016/j.biopha.2018.06.028
PMID:29909343
Abstract

This study aims to explore the effects and related mechanisms of Tanshinone IIA in cervix carcinoma (CC) stemness-like cells migration, invasion, stemness and chemotherapeutical sensitivity. Here, we found that Tanshinone IIA suppressed CC stemness-like cells migration and invasion in a concentration- and time-dependent manner. And consistent results were obtained in CC cells stemness characterized as the decrease of CC stemness markers expression and cells spheroid formation ability. Mechanistically, we found that Tanshinone IIA suppressed RNA binding protein HuR translocation from nuclear to cytoplasm, and thus reduced YAP mRNAs stability and transcriptional activity. Importantly, overexpression YAP-5SA rescued the inhibition of Tanshinone IIA on CC cells stemness. Furthermore, Tanshinone IIA enhanced adriamycin sensitivity in CC stemness-like cells, this effect was attenuated by YAP-5SA overexpression too. Therefore, Tanshinone IIA could suppress CC stemness-like cells migration and invasion by inhibiting YAP transcriptional activity.

摘要

本研究旨在探讨丹参酮 IIA 对宫颈癌(CC)干细胞样细胞迁移、侵袭、干性和化疗敏感性的影响及相关机制。研究发现,丹参酮 IIA 呈浓度和时间依赖性地抑制 CC 干细胞样细胞的迁移和侵袭。并且在 CC 细胞干性特征中也得到了一致的结果,表现为 CC 干性标志物表达降低和细胞球体形成能力下降。在机制上,研究发现丹参酮 IIA 抑制 RNA 结合蛋白 HuR 从核内易位到细胞质,从而降低 YAP mRNAs 的稳定性和转录活性。重要的是,过表达 YAP-5SA 可挽救丹参酮 IIA 对 CC 细胞干性的抑制作用。此外,丹参酮 IIA 增强了 CC 干细胞样细胞对阿霉素的敏感性,而过表达 YAP-5SA 也减弱了这种作用。因此,丹参酮 IIA 可以通过抑制 YAP 转录活性来抑制 CC 干细胞样细胞的迁移和侵袭。

相似文献

1
Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity.丹参酮 IIA 通过抑制 YAP 转录活性抑制宫颈癌干细胞的迁移和侵袭。
Biomed Pharmacother. 2018 Sep;105:758-765. doi: 10.1016/j.biopha.2018.06.028. Epub 2018 Jun 14.
2
Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.敲低 HuR 可通过抑制 YAP 的激活来抑制骨肉瘤细胞的迁移、侵袭和干性,并增加对化疗药物的敏感性。
Biomed Pharmacother. 2018 Jun;102:587-593. doi: 10.1016/j.biopha.2018.03.098. Epub 2018 Apr 5.
3
Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity.二甲双胍通过调节 YAP 活性抑制神经胶质瘤细胞干性和上皮-间充质转化。
Biomed Pharmacother. 2018 Jun;102:263-270. doi: 10.1016/j.biopha.2018.03.031. Epub 2018 Mar 22.
4
lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity.长链非编码 RNA B4GALT1-AS1 通过将 YAP 招募到细胞核并增强 YAP 转录活性促进结肠癌细胞干性和迁移。
J Cell Physiol. 2019 Aug;234(10):18524-18534. doi: 10.1002/jcp.28489. Epub 2019 Mar 25.
5
LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.长链非编码 RNA THOR 通过增强细胞干性来减弱鼻咽癌细胞对顺铂的敏感性。
Biochimie. 2018 Sep;152:63-72. doi: 10.1016/j.biochi.2018.06.015. Epub 2018 Jun 26.
6
Limonin attenuates the stemness of cervical carcinoma cells by promoting YAP nuclear-cytoplasmic translocation.柠烯通过促进 YAP 核质转位来减弱宫颈癌干细胞特性。
Food Chem Toxicol. 2019 Mar;125:621-628. doi: 10.1016/j.fct.2019.02.011. Epub 2019 Feb 7.
7
Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.丹参酮 IIA 通过诱导铁死亡抑制胃癌干细胞特性。
Environ Toxicol. 2022 Feb;37(2):192-200. doi: 10.1002/tox.23388. Epub 2021 Oct 18.
8
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.他汀类药物可抑制失活Hippo信号通路的恶性间皮瘤细胞,并阻断YAP/CD44生长刺激轴。
Cancer Lett. 2017 Jan 28;385:215-224. doi: 10.1016/j.canlet.2016.10.020. Epub 2016 Oct 20.
9
Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.丹参酮IIA抑制人胶质瘤干细胞的生长,减弱其干性并诱导其凋亡。
Oncol Rep. 2014 Sep;32(3):1303-11. doi: 10.3892/or.2014.3293. Epub 2014 Jun 26.
10
LncRNA B4GALT1-AS1 recruits HuR to promote osteosarcoma cells stemness and migration via enhancing YAP transcriptional activity.长链非编码 RNA B4GALT1-AS1 通过招募 HuR 增强 YAP 转录活性促进骨肉瘤细胞干性和迁移。
Cell Prolif. 2018 Dec;51(6):e12504. doi: 10.1111/cpr.12504. Epub 2018 Sep 4.

引用本文的文献

1
Tanshinone IIA alleviates tri-ortho-cresyl phosphate-induced ovarian damage through Hippo signaling pathway activation in mice.丹参酮IIA通过激活小鼠的Hippo信号通路减轻三邻甲苯基磷酸酯诱导的卵巢损伤。
J Ovarian Res. 2025 Apr 26;18(1):85. doi: 10.1186/s13048-025-01671-w.
2
Signaling pathways behind the biological effects of tanshinone IIA for the prevention of cancer and cardiovascular diseases.丹参酮IIA预防癌症和心血管疾病生物学效应背后的信号通路。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 12. doi: 10.1007/s00210-025-03857-x.
3
The mechanisms of tanshinone in the treatment of tumors.
丹参酮治疗肿瘤的机制。
Front Pharmacol. 2023 Oct 26;14:1282203. doi: 10.3389/fphar.2023.1282203. eCollection 2023.
4
An overview of the anti-cancer actions of Tanshinones, derived from (Danshen).源自丹参的丹参酮类化合物抗癌作用概述。
Explor Target Antitumor Ther. 2020;1(3):153-170. doi: 10.37349/etat.2020.00010. Epub 2020 Jun 29.
5
Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer.丹参酮对女性乳腺癌和妇科癌症的抗癌作用。
Front Pharmacol. 2022 Jan 25;12:824531. doi: 10.3389/fphar.2021.824531. eCollection 2021.
6
Tanshinone IIA attenuates the stemness of breast cancer cells via targeting the miR-125b/STARD13 axis.丹参酮IIA通过靶向miR-125b/STARD13轴减弱乳腺癌细胞的干性。
Exp Hematol Oncol. 2022 Jan 20;11(1):2. doi: 10.1186/s40164-022-00255-4.
7
Recent Research Progress (2015-2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA.丹参酮IIA药理作用及机制的近期研究进展(2015 - 2021年)与展望
Front Pharmacol. 2021 Nov 8;12:778847. doi: 10.3389/fphar.2021.778847. eCollection 2021.
8
Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer.植物源天然产物治疗宫颈癌的潜在机制。
Biomolecules. 2021 Oct 18;11(10):1539. doi: 10.3390/biom11101539.
9
Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.川芎内酯通过调节 Yes 相关蛋白介导体细胞因子 6 分泌抑制癌发生和肝癌细胞诱导的巨噬细胞 M2 极化。
Exp Biol Med (Maywood). 2021 Sep;246(17):1928-1937. doi: 10.1177/15353702211010420. Epub 2021 May 29.
10
Tanshinone IIA: A Review of its Anticancer Effects.丹参酮IIA:抗癌作用综述
Front Pharmacol. 2021 Jan 14;11:611087. doi: 10.3389/fphar.2020.611087. eCollection 2020.